Skip to content

Immunocore

US · IMCR #2968 by market cap Listed 2021
29.41 -0.14 -0.47%
Live - 5344 symbols - heartbeat 155s ago · 2026-10-07 19:54
After-hours 29.41 0.00%
Market cap
1.51B
P/B
3.61
EPS
-0.71
Reader sentiment Are you bullish or bearish on IMCR?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Goldman Sachs Maintains Immunocore(IMCR.US) With Buy Rating, Cuts Target Price to $72
    Market Newswire · 2026/2/26
  • Needham Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $75
    Market Newswire · 2026/8/7
  • Rating change
    Oppenheimer Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $86
    Market Newswire · 2026/4/20
  • J.P. Morgan Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $50
    Market Newswire · 2026/8/21
  • Rating change
    Needham Maintains Immunocore(IMCR.US) With Buy Rating, Raises Target Price to $75
    Market Newswire · 2026/2/26
  • Rating change
    TD Cowen Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $60
    Market Newswire · 2026/5/7
  • Rating change
    UBS Maintains Immunocore(IMCR.US) With Buy Rating, Raises Target Price to $55
    Market Newswire · 2026/1/8
  • Rating change
    Morgan Stanley Maintains Immunocore(IMCR.US) With Hold Rating, Maintains Target Price $40
    Market Newswire · 2026/2/26
  • Rating change
    Mizuho Securities Maintains Immunocore(IMCR.US) With Hold Rating, Maintains Target Price $38
    Market Newswire · 2026/4/15
  • Rating change
    Goldman Sachs Maintains Immunocore(IMCR.US) With Buy Rating, Raises Target Price to $73
    Market Newswire · 2026/5/7
  • Rating change
    Mizuho Securities Maintains Immunocore(IMCR.US) With Hold Rating, Raises Target Price to $38
    Market Newswire · 2026/2/19
  • Morgan Stanley Maintains Immunocore(IMCR.US) With Hold Rating, Raises Target Price to $43
    Market Newswire · 2026/8/7
  • Rating change
    Mizuho Securities Maintains Immunocore(IMCR.US) With Hold Rating, Cuts Target Price to $34
    Market Newswire · 2026/5/8
  • Rating change
    Immunocore Holdings (IMCR) Gets a Buy From H.C. Wainwright
    TipRanks · 2026/6/4
  • H.C. Wainwright Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $100
    Market Newswire · 2026/9/22
  • Rating change
    Morgan Stanley Maintains Immunocore(IMCR.US) With Hold Rating, Raises Target Price to $40
    Market Newswire · 2026/1/8
  • Rating change
    Wells Fargo Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $60
    Market Newswire · 2026/4/14
  • Rating change
    Mizuho Securities Maintains Immunocore(IMCR.US) With Hold Rating, Maintains Target Price $37
    Market Newswire · 2026/2/3
  • Goldman Sachs Maintains Immunocore(IMCR.US) With Buy Rating, Raises Target Price to $74
    Market Newswire · 2026/8/7
  • Rating change
    Jefferies Initiates Immunocore(IMCR.US) With Hold Rating, Announces Target Price $33
    Market Newswire · 2026/3/16

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.